Monday, November 10, 2014

The share of #Atara Biotherapeutics incorrectly traded at $200,000 a share at #Nasdaq which gave it a valuation of $3.88 trillion. The transactions were cancelled subsequently.

The share of Atara Biotherapeutics incorrectly traded at $200,000 a share at Nasdaq which gave it a valuation of $3.88 trillion. The transactions were cancelled subsequently.
http://www.wikio.co.uk